Simon and Séverine are the co-founders of IDUN Technologies. Their recently debuted Dryode™ Kit is the result of their research at ETH Zurich. We wanted to learn a bit more about what drew them to the biosensing / wearables space, and what plans they have for IDUN’s future.
How did you first get involved in the wearables space? What inspired you to start IDUN?
We met during our studies at ETH Zurich. We started IDUN Technologies with the vision to shift healthcare from being reactive to being preventive. For that, continuous monitoring with accurate signal quality is necessary. For biopotential wearables (ECG, EMG, EEG) the electrode seemed to be the most crucial missing part.
What was the most challenging part of getting started and making the Dryode a reality?
Next to the normal insanity of running your own company (fundraising, hiring people, legal etc.) it was always hard to figure out on what we want to focus first. Since the Dryode™ technology can be used for so many different things it was always a challenge to figure out where to start. It seems like a nice irony that we ended up where we started – in research.
What sets IDUN apart from other options?
IDUN products offer clinical grade signal quality with lifestyle comfort. Our electrodes are flexible, stretchable and reusable. They provide a skin-friendly and water resistant alternatives to disposable wet electrodes. Additionally, the material properties provide motion artifact reduction
What is the most interesting application of the Dryode that you’ve seen so far?
Sleep EEG monitoring for insomniacs, sports diagnostics for professional biathlon athletes or ECG recordings for a bronze medal free diver world champion were pretty exciting to work with. However, we can’t wait to see the crazy applications that the OpenBCI community will come up with!
What’s next on the roadmap for IDUN?
We have many exciting products in our pipeline. We are developing other designs for 2D and 3D structured electrodes connecting users in everyday life for the Internet of Humans.